tm logo
ALLERGAN
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 20 Aug 2024

Last Applicant/ Owned by

1 N. Waukegan Road

North Chicago

IL

60064

Serial Number

86983196 filed on 12th Jun 2015

Registration Number

5443889 registered on 10th Apr 2018

in the Principal Register

Correspondent Address

Cheryl A. Withycombe

Cheryl A. Withycombe AbbVie Inc.

Mail Stop: AND-250C

Irvine, CA 92612

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ALLERGAN

House mark used for a line of surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar lin Read More

Classification Information


Class [010]
Medical Instrument Products


House mark used for a line of surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics and ophthalmic related diseases and disorders


First Use Date in General

12th Oct 2016

First Use Date in Commerce

12th Oct 2016

Class [005]
Pharmaceutical Products


House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, and pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations


First Use Date in General

30th Jun 2017

First Use Date in Commerce

30th Jun 2017

Mark Details


Serial Number

No 86983196

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ABVT116624

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.01.07 -

Stars with tails or comets

26.01.21 -

Circles that are totally or partially shaded

26.01.31 -

Five or more circles

29.03.03 -

Blue

29.03.06 -

Green

29.06.03 -

Blue

29.06.06 -

Green

Legal History


Show more

Status DateAction Taken
20th Aug 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
20th Aug 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
20th Aug 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05th Feb 2024TEAS SECTION 8 & 15 RECEIVED
10th Apr 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10th Apr 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10th Apr 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
10th Apr 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10th Apr 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
10th Apr 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED